Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

Advanced prostate cancer remains incurable and is the second leading cause of mortality in men. Immunotherapy based on the adoptive transfer of tumor-infiltrating lymphocytes (TIL) has demonstrated promising clinical results in patients with metastatic melanoma and lately also in other solid tumors....

詳細記述

書誌詳細

主要な著者:	Sharon Yunger, Assaf Bar El, Li-at Zeltzer, Eddie Fridman, Gil Raviv, Menachem Laufer, Jacob Schachter, Gal Markel, Orit Itzhaki, Michal J Besser
フォーマット:	Artigo
言語:	Inglês
出版事項:	Taylor & Francis Group 2019-12-01
シリーズ:	OncoImmunology
主題:	adoptive cell therapy (act) tumor infiltrating lymphocyte (til) prostate cancer (pca) immunotherapy primary prostate cancer cultures
オンライン･アクセス:	http://dx.doi.org/10.1080/2162402X.2019.1672494
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!